Spagnolin, M.; Fazzini, L.; Terzi, A.; Iacovoni, A.; Abete, R.; Zucchetti, O.; Senni, M.; Gori, M.
Ethical Considerations Regarding Advanced Heart Failure Therapies in Patients Affected by Dystrophinopathies. Cardiogenetics 2025, 15, 26.
https://doi.org/10.3390/cardiogenetics15030026
AMA Style
Spagnolin M, Fazzini L, Terzi A, Iacovoni A, Abete R, Zucchetti O, Senni M, Gori M.
Ethical Considerations Regarding Advanced Heart Failure Therapies in Patients Affected by Dystrophinopathies. Cardiogenetics. 2025; 15(3):26.
https://doi.org/10.3390/cardiogenetics15030026
Chicago/Turabian Style
Spagnolin, Marco, Luca Fazzini, Amedeo Terzi, Attilio Iacovoni, Raffaele Abete, Ottavio Zucchetti, Michele Senni, and Mauro Gori.
2025. "Ethical Considerations Regarding Advanced Heart Failure Therapies in Patients Affected by Dystrophinopathies" Cardiogenetics 15, no. 3: 26.
https://doi.org/10.3390/cardiogenetics15030026
APA Style
Spagnolin, M., Fazzini, L., Terzi, A., Iacovoni, A., Abete, R., Zucchetti, O., Senni, M., & Gori, M.
(2025). Ethical Considerations Regarding Advanced Heart Failure Therapies in Patients Affected by Dystrophinopathies. Cardiogenetics, 15(3), 26.
https://doi.org/10.3390/cardiogenetics15030026
